{
    "testId": 378043569,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 31,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 13,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 1,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 811,
    "averageTimeSpentInSeconds": 139,
    "otherAverageTimeSpentInSeconds": 75,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 20,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 7708,
            "questionIndex": 7708,
            "questionText": "<table border=\"0\" cellpadding=\"5\" cellspacing=\"0\" width=\"100%\"><tbody><tr><td bgcolor=\"#c0c0c0\" width=\"100%\">The drug ad applies to the next <strong>2</strong> items.</td></tr></tbody></table><p>The 3-page drug ad is focused on Efrenzia, a novel anti-platelet agent for the treatment of acute coronary syndrome.</p><p><strong>Item 1 of 2</strong></p><p>A 58-year-old man with a history of hypertension and type 2 diabetes mellitus comes to the emergency department because of chest pain and diaphoresis.&nbsp; The symptoms started 2 hours ago and have a stuttering course.&nbsp; He has never had similar symptoms before.&nbsp; In the emergency department, his electrocardiogram shows horizontal ST segment depression in leads V1 to V4.&nbsp; He is given the appropriate medical therapy including low-dose aspirin and referred to the catheterization laboratory due to persistence of his angina.&nbsp; Based on the information provided in the drug ad, giving the patient Efrenzia as opposed to clopidogrel would most likely decrease the risk of developing which of the following events?</p>",
            "questionHeader": "",
            "explanationText": "<p>This drug ad is comparing the effect of administering Efrenzia + aspirin versus clopidogrel + aspirin for patients with acute coronary syndrome undergoing percutaneous coronary intervention.&nbsp; Patients were divided into 2 groups: those with unstable angina (UA)/non-ST elevation myocardial infarction (NSTEMI) and those with ST-elevation myocardial infarction (STEMI).&nbsp; The results are reported as the percentage of patients developing a composite endpoint of cardiovascular death, non-fatal myocardial infarction (MI), or nonfatal stroke over the subsequent 18 months.&nbsp; A subgroup analysis was also performed in patients with diabetes who had UA/NSTEMI or STEMI.</p><p>There was a 2.7% overall decrease of events in patients with STEMI (12.4% reduced to 9.7%) and a 1.8% decrease of events in patients with UA/NSTEMI (10.7% reduced to 8.9%).&nbsp; The <a href=\"1351\">third page</a> of the drug ad indicates that the difference between the treatments was primarily due to a reduction in non-fatal MIs; there was no significant difference in cardiovascular death or non-fatal stroke <strong>(Choices A and C)</strong>.&nbsp; As a result, giving this patient Efrenzia as opposed to clopidogrel would most likely decrease his risk of having another (ie, recurrent) MI.</p><p><strong>(Choice B)</strong>&nbsp; Major bleeding was not part of the primary composite endpoint.&nbsp; Also, the safety data at the end of the drug ad indicates that overall bleeding rates were significantly increased with Efrenzia.</p><p><strong>Educational objective:</strong><br>When comparing the effects of a treatment on a composite outcome, it is important to note any differences between the individual endpoints.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24338,
            "topic": "Interpretation and use of evidence-based data (including individualization, risk-benefit analysis, synthesis of concepts with real data)",
            "titleId": 24338,
            "title": "Interpretation and use of evidence-based data (including individualization, risk-benefit analysis, synthesis of concepts with real data)",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 7708,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cardiovascular death",
                    "choiceNumber": 1,
                    "correctTaken": 23687,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major bleeding",
                    "choiceNumber": 2,
                    "correctTaken": 7477,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Non-fatal stroke",
                    "choiceNumber": 3,
                    "correctTaken": 13759,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recurrent myocardial infarction",
                    "choiceNumber": 4,
                    "correctTaken": 66404,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12759327",
                    "mediaDataId": 0,
                    "title": "Composite outcomes in randomized trials: greater precision but with greater uncertainty?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12759327",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": {
                "id": 295,
                "fileName": "L18977.jpg;L18978.jpg;L18979.jpg",
                "typeId": 1,
                "title": "Efrenzia",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 243,
            "othersAvgTimeSpent": 93,
            "notes": null,
            "peopleTaken": 111327,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 685,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 7709,
            "questionIndex": 7709,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>Based on the drug ad data, how many patients with diabetes undergoing percutaneous coronary intervention for unstable angina (UA)/non-ST segment elevation myocardial infarction (NSTEMI) need to be treated with Efrenzia to prevent 1 additional composite event as compared to clopidogrel?</p>",
            "questionHeader": "",
            "explanationText": "<p>The number needed to treat (NNT) is defined as the number of people that need to receive a treatment to prevent 1 additional adverse event.&nbsp; It is calculated as the inverse of the absolute risk reduction (ARR).&nbsp; As listed on the second page of the ad, in this <a href=\"1352\">study</a>, patients with diabetes who had UA/NSTEMI had a 16.3% incidence of composite events with clopidogrel + aspirin and 12.3% with Efrenzia + aspirin.</p><p align=\"center\">ARR = 0.163 &ndash; 0.123 = 0.04</p><p align=\"center\">NNT = 1/ARR = 1/0.04 = 25</p><p>Compared to clopidogrel, Efrenzia would need to be given to at least 25 patients with diabetes undergoing percutaneous coronary intervention for UA/NSTEMI in order to prevent 1 additional composite event <strong>(Choices A, B, D, and E)</strong>.</p><p><strong>Educational objective:</strong><br>The number needed to treat (NNT) is defined as the number of people that need to receive a treatment to prevent 1 additional adverse event.&nbsp; It is calculated as the inverse of the absolute risk reduction (ARR).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 1652,
            "topic": "Number Needed To Treat",
            "titleId": 1652,
            "title": "Number Needed To Treat",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 7708,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "5",
                    "choiceNumber": 1,
                    "correctTaken": 14220,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "10",
                    "choiceNumber": 2,
                    "correctTaken": 8838,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "25",
                    "choiceNumber": 3,
                    "correctTaken": 72393,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "50",
                    "choiceNumber": 4,
                    "correctTaken": 11154,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "100",
                    "choiceNumber": 5,
                    "correctTaken": 3520,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21473250",
                    "mediaDataId": 0,
                    "title": "How effective is that treatment? The number needed to treat.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21473250",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": {
                "id": 295,
                "fileName": "L18977.jpg;L18978.jpg;L18979.jpg",
                "typeId": 1,
                "title": "Efrenzia",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 266,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 110125,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 325,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 7688,
            "questionIndex": 7688,
            "questionText": "<TABLE border=0 cellSpacing=0 cellPadding=5 width=\"100%\"><TBODY><TR><TD bgColor=#c0c0c0 width=\"100%\">The abstract shown on the left applies to the next <B>2</B> items</TD></TR></TBODY></TABLE><P><B>Item 1 of 2</B></P><P>A 43-year-old African American male with a strong family history of hypertension presents to the office with generalized fatigue.&nbsp; His past medical history is noncontributory.&nbsp; He is an active smoker.&nbsp; He is currently taking metoprolol.&nbsp; His blood pressure is 162/100 mmHg and his pulse is 76/min.&nbsp; The apical impulse is laterally displaced.&nbsp; His physical examination is otherwise unremarkable.&nbsp; EKG shows high voltage consistent with left ventricular hypertrophy with secondary repolarization changes.&nbsp; His serum potassium is 3.9 mEq/L and estimated GFR is 36 mL/min/1.73 m<SUP><FONT size=2>2</FONT></SUP>.&nbsp; His baseline UP/Cr is 0.20.&nbsp; The patient is started on an ACE inhibitor and he shows compliance with follow-up visits.&nbsp; Based on study results, which of the following factors on follow-up will most significantly increase his chance of hyperkalemia event?</P>",
            "questionHeader": "",
            "explanationText": "<P>This study is a double-blinded randomized clinical trial comparing the incidence of hyperkalemia in African-American (non-diabetic) patients with CKD and hypertension (diastolic greater than 95 mm Hg).&nbsp; The patients were randomized to either metoprolol, amlodipine, or ramipril and followed up to 6 years.&nbsp; The primary endpoint was the incidence of hyperkalemia, defined as greater than 5.5 mEq/L.&nbsp; The results were reported as events per 100 patient years and also reported as hazard ratios.</P><P>Hazard ratio is the ratio of an event rate occurring in the treatment group compared to an event rate occurring in the non-treatment group.&nbsp; A ratio less than 1 indicates that the treatment group had a significantly lower event rate while values greater than 1 indicate that the treatment group had a much higher event rate.&nbsp; In this study, the risk factors for developing hyperkalemia were reported as hazard ratios.&nbsp; The higher the ratio, the more likely that factor is associated with the incidence of hyperkalemia.&nbsp; The factor that had the highest ratio (of the choices listed) is a follow-up serum potassium level between 4-5 mEq/L as compared to less than 4 mEq/L, with a hazard ratio of 7.25.</P><P><B>(Choice A)</B>&nbsp; As shown in the results figure, patients with a GFR between 30-40 mL/min/1.73 m<SUP><FONT size=2>2 </FONT></SUP>given amlodipine actually had a lower incidence of hyperkalemia per 100 patient years than ramipril.</P><P><B>(Choice B)</B>&nbsp; The hazard ratio for follow-up use of a diuretic was 0.41 (with a statistically significant p value &lt;0.01), indicating that adding a diuretic is associated with a lower incidence of hyperkalemia.</P><P><B>(Choice C)</B>&nbsp; This patient is already on metoprolol and has a normal potassium.&nbsp; The addition of metoprolol in the study did not significantly increase the incidence of hyperkalemia in patients with GFR &gt;30 and &#x2264;40 according to the figure above, so discontinuation of the drug likely would not have a significant effect on the potassium.</P><P><B>(Choice E)</B>&nbsp; Follow-up UP/Cr of 1.1 as compared to baseline has a hazard ratio of 1.84, indicating that there is an increased incidence of hyperkalemia.&nbsp; However, this ratio is lower than the hazard ratio for follow-up potassium level between 4-5 mEq/L and it is not statistically significant (p=0.16).</P><P><B>Educational objective:</B><BR>Hazard ratios are the ratio of an event rate occurring in the treatment arm versus the non-treatment arm.&nbsp; Ratios less than 1 indicate that the treatment arm had a lower event rate while ratios higher than one indicate the treatment arm had a higher rate of events.</P>",
            "abstractId": 2,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15219,
            "topic": "Randomized control trials",
            "titleId": 15219,
            "title": "Randomized control trials",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 7688,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Addition of a calcium channel blocker",
                    "choiceNumber": 1,
                    "correctTaken": 11653,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Addition of a thiazide diuretic",
                    "choiceNumber": 2,
                    "correctTaken": 14420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinuation of metoprolol",
                    "choiceNumber": 3,
                    "correctTaken": 8572,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Follow-up serum potassium level of 4.7 meq/l as compared to baseline",
                    "choiceNumber": 4,
                    "correctTaken": 123221,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Follow-up UP/Cr of 1.1 as compared to baseline",
                    "choiceNumber": 5,
                    "correctTaken": 15796,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21623277",
                    "mediaDataId": 0,
                    "title": "Biostatistics primer: what a clinician ought to know: hazard ratios.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21623277",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20860993",
                    "mediaDataId": 0,
                    "title": "Estimation of the 2-sample hazard ratio function using a semi parametric model.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20860993",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 400,
            "othersAvgTimeSpent": 93,
            "notes": null,
            "peopleTaken": 173662,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1590,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 7689,
            "questionIndex": 7689,
            "questionText": "<P><B>Item 2 of 2</B></P><P>For the study, patients were randomized to initial treatment with either a beta-blocker (metoprolol), an ACE inhibitor (ramipril), or a calcium channel blocker (amlodipine) and to 1 of 2 mean arterial BP goals (102-107 mmHg or &lt;92 mmHg).&nbsp; The study is best classified as:</P>",
            "questionHeader": "",
            "explanationText": "<P><a href=\"34\">Factorial Design Study Exhibit</a></P><P>This study utilizes 3 different interventions (metoprolol, ramipril, amlodipine) with 2 different variable blood pressure endpoints (102-107 mm Hg or &lt;92 mm Hg), which is consistent with a factorial design study.&nbsp; A factorial design (as shown above) involves 2 or more experimental interventions, each with 2 or more variables that are studied independently.&nbsp; In this study, the patients were being investigated to see which one of these 3 drugs caused hyperkalemia with the greatest frequency.&nbsp; In addition, the drugs also had 2 different blood pressure end points rather than one common end point to see what effect they also had on blood pressure.</P><P><B>(Choice A)</B>&nbsp; Cluster analysis is the grouping of different data point into similar categories, which is not employed in this study.&nbsp; Cluster analysis usually involves randomization at the level of groups rather than at the level of individuals.</P><P><B>(Choice B)</B>&nbsp; A cross-over study is one in which group of participants is randomized to one treatment for a period of time and the other group is given an alternate treatment for the same period of time.&nbsp; At the end of the time period, the two groups then switch treatments for another set period of time.&nbsp; This study gave the same treatment to the patients for the duration of the trial.</P><P><B>(Choice D)</B>&nbsp; A parallel study randomizes one treatment to one group and a different treatment to the other group, such as treatment drug to one group versus placebo to the other group.&nbsp; There are usually no other variables measured, such as the two blood pressure goals in this study.</P><P><B>Educational objective:</B><BR>Factorial design studies involve randomization to different interventions with additional study of 2 or more variables.</P>",
            "abstractId": 2,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15219,
            "topic": "Randomized control trials",
            "titleId": 15219,
            "title": "Randomized control trials",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 7688,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cluster",
                    "choiceNumber": 1,
                    "correctTaken": 20365,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cross-over",
                    "choiceNumber": 2,
                    "correctTaken": 19047,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factorial design",
                    "choiceNumber": 3,
                    "correctTaken": 53678,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parallel-group",
                    "choiceNumber": 4,
                    "correctTaken": 80225,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": "842,955,true,-1,1*274,419,true,-1,1*1354,1525,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19719358",
                    "mediaDataId": 0,
                    "title": "Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19719358",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 30,
            "notes": null,
            "peopleTaken": 173315,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 31,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 829,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 18803,
            "questionIndex": 20279,
            "questionText": "<p>A group of epidemiologists studied tinnitus and various possible factors associated with the condition in a representative sample of the adult population in a particular city in the United States.&nbsp; The data collected in the study represent the civilian, noninstitutionalized population in this city using stratified, multistage, clustered, random sampling based on census data.&nbsp; A total of 2,645 adults age 21-98 were invited to participate, 91% of whom completed the study.&nbsp; Data on the presence of tinnitus, as well as on personal, socioeconomic, and otologic factors, were collected.&nbsp; Results showed that age, gender, stress, status as a soldier, hearing loss, noise exposure with earphones, noise exposure at the workplace, noise exposure at locations other than the workplace, and brief noise exposure are associated with tinnitus.&nbsp; Which of the following best describes this study design?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p><strong>Research studies</strong> are broadly classified as having an observational design or an experimental design depending on the control the researchers have over the independent variables.</p><ul><li><p>In <strong>observational studies</strong> (eg, case series, case-control studies, cohort studies, cross-sectional studies), the researchers have <strong>no control</strong> over the independent variables (eg, exposure to risk factors, treatments).</p></li><li><p>In experimental studies (eg, randomized controlled trials), the researchers control and randomly assign the independent variables (eg, treatments).</p></li></ul><p>A <strong>cross-sectional study</strong> is an observational study that is used to <strong>estimate prevalence of disease</strong>, but it may also be used to examine <strong>associations</strong> between <strong>risk factors and disease</strong> in a well-defined population at one <strong>particular time</strong>.&nbsp; This type of study typically takes a <strong>snapshot</strong> of a population and measures frequency of risk factors and disease simultaneously.</p><p>In this study, participants are classified according to risk factors (eg, age, gender, stress, hearing loss) and disease status (ie, presence or absence of tinnitus) at the same time (ie, snapshot).&nbsp; Then, the association between risk factor and disease is evaluated.&nbsp; A major limitation of cross-sectional studies is that the temporal relationship between risk factor and disease is not always clear.</p><p><strong>(Choices A and C)</strong>&nbsp; In a case-control study, 2 groups of individuals are initially identified as &#x22;cases&#x22; or &#x22;controls&#x22; according to an outcome (eg, disease of interest) and then assessed on their past exposure to risk factors.&nbsp; In contrast, in a cohort study, 2 groups of individuals are initially identified as &#x22;exposed&#x22; or &#x22;nonexposed&#x22; according to their exposure status to a specific risk factor and then followed over time to assess development of the outcome.&nbsp; In this example, individuals were assessed for exposure to risk factors and disease at the same time (ie, snapshot).</p><p><strong>(Choice B)</strong>&nbsp; In a case series, a small group of patients with a similar diagnosis or treatment is described at a point in time or followed over a certain period.&nbsp; This observational study has no comparison group, so it cannot establish associations between risk factors and disease.</p><p><strong>(Choice E)</strong>&nbsp; In a randomized controlled trial, participants are randomly assigned to &#8805;1 interventions to evaluate the effects of those interventions on outcomes of interest.</p><p><strong>Educational objective:</strong><br>A cross-sectional study is an observational study commonly used to estimate the prevalence of disease, but it may also be used to examine associations between potential risk factors and disease.&nbsp; However, exposure to risk factors and disease status are measured simultaneously at a particular point in time (ie, snapshot).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Case-control study",
                    "choiceNumber": 1,
                    "correctTaken": 540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Case series",
                    "choiceNumber": 2,
                    "correctTaken": 242,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cohort study",
                    "choiceNumber": 3,
                    "correctTaken": 629,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cross-sectional study",
                    "choiceNumber": 4,
                    "correctTaken": 4158,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Randomized controlled trial",
                    "choiceNumber": 5,
                    "correctTaken": 49,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 118,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 5618,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 11,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 20033,
            "questionIndex": 21526,
            "questionText": "<p>A 42-year-old woman comes to the office for follow-up after knee replacement surgery.&nbsp; BMI is 35.8 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient does not engage in physical activity due to her knee problems but says she is willing to try radical changes in her eating habits if it will help her lose weight.&nbsp; She read an article that compared the effects of alternate-day fasting (ADF) versus daily calorie restriction (DCR) on weight loss in adults.&nbsp; A total of 200 obese participants were randomly assigned to either ADF or DCR.&nbsp; The trial involved a 12-month weight-loss phase with outcomes measured at baseline and at 12 months.&nbsp; The primary outcome was change in body weight, and the secondary outcomes were adherence to the dietary intervention and change in cardiometabolic risk factors.&nbsp; The study reported a statistically significant (<em>p</em> &lt; 0.05) reduction in body weight and cardiometabolic risk indicators in both groups.&nbsp; The difference in change from baseline to 12 months between groups is shown below.</p><div id=\"div_T70151\"><table class=\"table-default-style table-footer-only-style table-remove-header-borders-style\" style=\"width:540px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Effects of ADF vs DCR on weight loss<br>and cardiometabolic risk factors at 12 months</strong></p></td></tr><tr><td><p align=\"center\"><strong>Outcomes</strong></p></td><td><p align=\"center\"><strong>Change in ADF &#8722; Change in DCR<br>(95% CI)</strong></p></td></tr><tr><td><p>Body weight (% change)</p></td><td><p align=\"center\">&#8722;0.7<br>(&#8722;3.1 to 1.6)*</p></td></tr><tr><td style=\"white-space:nowrap\"><p>Systolic blood pressure (mm Hg)</p></td><td><p align=\"center\">&#8722;1.1<br>(&#8722;9.5 to 7.4)**</p></td></tr><tr><td style=\"white-space:nowrap\"><p>Diastolic blood pressure (mm Hg)</p></td><td><p align=\"center\">&#8722;3.0<br>(&#8722;9.0 to 3.0)**</p></td></tr><tr><td><p>Total cholesterol (mg/dL)</p></td><td><p align=\"center\">9.7<br>(&#8722;2.2 to 21.7)**</p></td></tr><tr><td><p>HDL cholesterol (mg/dL)</p></td><td><p align=\"center\">1.0<br>(&#8722;5.9 to 7.8)**</p></td></tr><tr><td><p>LDL cholesterol (mg/dL)</p></td><td><p align=\"center\">9.6<br>(&#8722;1.9 to 21.1)**</p></td></tr><tr><td><p>Triglycerides (md/dL)</p></td><td><p align=\"center\">&#8722;9.9<br>(&#8722;28.3 to 8.6)**</p></td></tr><tr><td><p>Glucose (mg/dL)</p></td><td><p align=\"center\">5.7<br>(&#8722;1.6 to 13.0)**</p></td></tr><tr><td><p>Insulin (&micro;IU/mL)</p></td><td><p align=\"center\">&#8722;1.3<br>(&#8722;6.9 to 4.3)**</p></td></tr><tr><td colspan=\"2\"><p><strong>ADF</strong> = alternate-day fasting; <strong>CI</strong> = confidence interval; <strong>DCR</strong> = daily calorie restriction; <strong>HDL</strong> = high-density lipoprotein; <strong>LDL</strong> = low-density lipoprotein.</p><p>*CI for a difference in percent change between groups.</p><p>**CI for a difference in mean change between groups.</p></td></tr></tbody></table></div><p>Adverse effects such as migraines and low energy were reported by 24% of participants in the ADF group and by 32% of participants in the DCR group (<em>p</em> = 0.21).&nbsp; The study reported that 12% of participants could not tolerate ADF and switched to DCR.&nbsp; Based on these data, which of the following is the most appropriate recommendation for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This study compares the effects of 2 diets&mdash;alternate-day fasting (ADF) and daily calorie restriction (DCR)&mdash;on weight loss, as well as adherence to the dietary intervention and cardiometabolic risk indicators in obese adults.&nbsp; The results of the study are presented as the <strong>difference in change</strong> from baseline to 12 months between groups (ie, ADF &#8722; DCR), including 95% confidence intervals (CIs) for the difference between groups.&nbsp; A difference in change between groups is <strong>not statistically significant</strong> when the <strong>CI includes the null value</strong> (ie, difference = 0) and is statistically significant when the CI excludes the null value.</p><p>In this study, the <strong>CIs</strong> for the difference in body weight percent change, systolic and diastolic blood pressure, cholesterol, triglycerides, and glucose levels between groups <strong>includes 0</strong> (ie, the null value); therefore, there is <strong>no significant difference</strong> in <strong>weight loss</strong> and <strong>cardiometabolic risk indicators</strong> between groups <strong>(Choices A and D)</strong>.</p><p>The study results also indicate that 24% of participants in the ADF group and 32% of participants in the DCR group reported adverse effects (ie, migraines, low energy).&nbsp; However, the difference in the incidence of adverse events between groups was not statistically significant (<em>p</em> = 0.21) <strong>(Choice B)</strong>.</p><p>Finally, the study reported that 12% (not most) of patients in the ADF group could not tolerate the intervention and switched to DCR <strong>(Choice C)</strong>.&nbsp; Based on these results, neither diet is superior regarding weight loss, adverse effects, or improvement in cardiometabolic risk indicators.&nbsp; Therefore, either the ADF or DCR diet may be recommended to the patient.</p><p><strong>Educational objective:</strong><br>The null value of a confidence interval (CI) for a difference (percent change or mean change) between 2 groups is always 0, indicating there is no difference between the groups.&nbsp; A CI that includes the null value (ie, difference = 0) is not statistically significant, and a CI that excludes the null value is statistically significant.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24197,
            "topic": "Statistical vs. clinical significance",
            "titleId": 24197,
            "title": "Statistical vs. clinical significance",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "ADF because of the greater reduction in body weight",
                    "choiceNumber": 1,
                    "correctTaken": 762,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "ADF because of the high incidence of adverse effects in the DCR group",
                    "choiceNumber": 2,
                    "correctTaken": 471,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "DCR because most participants in the ADF group switched to DCR",
                    "choiceNumber": 3,
                    "correctTaken": 819,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "DCR because of the greater reduction in cholesterol values",
                    "choiceNumber": 4,
                    "correctTaken": 749,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Either ADF or DCR because the outcomes are similar",
                    "choiceNumber": 5,
                    "correctTaken": 7722,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 196,
            "othersAvgTimeSpent": 142,
            "notes": null,
            "peopleTaken": 10523,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 338,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 4121,
            "questionIndex": 4121,
            "questionText": "A large-scale randomized, double-blinded clinical trial was conducted to evaluate the effect of beta-blocker therapy on the survival of patients with chronic heart failure, class IV.&nbsp; The patients with severe heart failure were randomly assigned to receive either carvedilol (a beta blocker) or a placebo.&nbsp; In their report of the results of the study, the investigators included a table with baseline characteristics (eg, age, race, prevalence of hypertension) of the patients in the treatment and placebo groups.&nbsp; According to that table, both groups had a similar distribution of these characteristics.&nbsp; With the information given, which of the following is most probable?",
            "questionHeader": "",
            "explanationText": "<p>The purpose of <strong>randomization</strong> is to make the distribution of all potential confounders even (eg, between the treatment and placebo groups).&nbsp; Unlike all the other methods of <strong>controlling confounding</strong> (eg, matching, stratified analysis), randomization potentially controls <strong>known as well as unknown</strong> confounders.</p><p>One of the methods to assess the adequacy of randomization is to look at the distribution of <strong>baseline characteristics</strong> in both groups.&nbsp; If they are similar, one can assume that the randomization evenly distributed the confounders between the groups, and that randomization was successful.</p><p><strong>(Choices A and C)</strong>&nbsp; From the information given, it is not possible to judge the adequacy of the sample size to detect the difference in the survival (if it is present) between the treatment and placebo groups.&nbsp; It is also not possible to assess the power of the study (which depends on the sample size) based on the above information.</p><p><strong>(Choice B)</strong>&nbsp; The results of the study were not mentioned.</p><p><strong>(Choice E)</strong>&nbsp; Observer bias can be controlled with blinding, not randomization.</p><p><strong>Educational objective:</strong><br>In clinical trials, randomization is said to be successful when a similarity of baseline characteristics of the patients in the treatment and placebo groups is seen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15219,
            "topic": "Randomized control trials",
            "titleId": 15219,
            "title": "Randomized control trials",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The sample size is adequate",
                    "choiceNumber": 1,
                    "correctTaken": 12405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The study is negative",
                    "choiceNumber": 2,
                    "correctTaken": 8227,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The power of the study is big",
                    "choiceNumber": 3,
                    "correctTaken": 20267,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Randomization is successful",
                    "choiceNumber": 4,
                    "correctTaken": 230392,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer bias might be an issue",
                    "choiceNumber": 5,
                    "correctTaken": 24464,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 295755,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 702,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 18892,
            "questionIndex": 20371,
            "questionText": "<p>A cohort study compares the survival rates of patients with type 2 diabetes mellitus (T2DM) undergoing hemodialysis (HD) at 2 different large, for-profit dialysis centers.&nbsp; Patients with T2DM receiving HD treatment at both centers (<em>n</em> = 520) are followed for 5 years.&nbsp; An excerpt of the results of the study is shown below.</p><div id=\"div_t64438\"><table class=\"table-default-style table-footer-only-style\" style=\"width:576px\"><tbody><tr><td><p align=\"center\"><strong>Dialysis center</strong></p></td><td><p align=\"center\"><strong>5-year survival rate*</strong></p></td><td><p align=\"center\"><strong><em>p</em></strong><strong>-value</strong></p></td></tr><tr><td><p align=\"center\"><strong>Center A</strong> (<em>n</em> = 285)</p></td><td><p align=\"center\">38.6%</p></td><td rowspan=\"2\"><p align=\"center\">0.0278</p></td></tr><tr><td><p align=\"center\"><strong>Center B</strong> (<em>n</em> = 235)</p></td><td><p align=\"center\">29.4%</p></td></tr><tr><td colspan=\"3\"><p>*Analysis adjusted for age and sex.</p></td></tr></tbody></table></div><p>Researchers conclude that, compared to Center A, the quality of HD treatment at Center B is suboptimal.&nbsp; Based on the information given, which of the following potential flaws is most likely to invalidate this conclusion?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Confounding bias</strong> occurs when a study does not control for <strong>extraneous variables</strong> independently related to both the risk factor (ie, independent variable) and the outcome (ie, dependent variable).&nbsp; When not controlled, confounders may <strong>mask the true effect</strong> that the independent variable has on the dependent variable, which may lead to <strong>false conclusions</strong> (ie, statistically significant results that are truly invalid).</p><p>This cohort study compared 5-year survival rates (ie, outcome) among patients with type 2 diabetes mellitus (T2DM) undergoing hemodialysis (HD) at 2 different centers (ie, risk factor).&nbsp; The study adjusted (ie, controlled) for age and sex; however, it did not adjust for comorbidities (eg, cardiovascular disease, hypertension).&nbsp; <strong>Failing to adjust</strong> for <strong>comorbidities</strong> may lead to <strong>confounding bias</strong>.&nbsp; For example, if Center B treats significantly more patients with hypertension or congestive heart failure compared to Center A, then this may lower Center B&#39;s 5-year survival rate.&nbsp; Therefore, failing to adjust for comorbidities in the study <strong>potentially distorted</strong> (ie, masked) the <strong>true difference in 5-year survival rates</strong> between centers.</p><p><strong>(Choice A)</strong>&nbsp; The adequate follow-up time in cohort studies depends on various factors, including the time required to observe a sufficiently large number of outcomes (eg, deaths) in each study group to make valid statistical inferences.&nbsp; Use of 5-year survival rates is adequate for conditions with a relatively shorter life expectancy (greater number of outcomes in a short amount of time), such as patients with T2DM undergoing HD.</p><p><strong>(Choices B and E)</strong>&nbsp; The absolute difference in 5-year survival rate among patients undergoing HD at Centers A and B is 38.6% &#8722; 29.4% = 9.2%; this difference is clinically significant.&nbsp; The difference is also statistically significant (<em>p</em> = 0.0278 &lt; 0.05).</p><p><strong>(Choice D)</strong>&nbsp; Failure to show a statistically significant difference between 2 groups is often due to insufficient power (eg, due to a small sample size) to detect that difference.&nbsp; These study results showed a statistically significant difference in 5-year survival rate between the 2 centers after adjusting for age and sex, so the study had sufficient power to detect that difference.</p><p><strong>Educational objective:</strong><br>Confounding bias occurs when an extraneous (ie, confounding) variable masks the relationship between an independent variable (eg, risk factor, treatment) and a dependent variable (ie, outcome, disease of interest).&nbsp; It may lead to false conclusions (ie, statistically significant results that are truly invalid).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The follow-up time is inadequate",
                    "choiceNumber": 1,
                    "correctTaken": 70,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The results are not clinically relevant",
                    "choiceNumber": 2,
                    "correctTaken": 177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The statistical analysis did not adjust for comorbidities",
                    "choiceNumber": 3,
                    "correctTaken": 4985,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The study is significantly underpowered",
                    "choiceNumber": 4,
                    "correctTaken": 172,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is no statistically significant difference in survival rates between the centers",
                    "choiceNumber": 5,
                    "correctTaken": 259,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 5663,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 88,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 318,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 11512,
            "questionIndex": 12673,
            "questionText": "<table border=\"0\" cellpadding=\"5\" cellspacing=\"0\" width=\"100%\"><tbody><tr><td bgcolor=\"#c0c0c0\">The abstract shown on the left applies to the next <strong>2</strong> items.</td></tr></tbody></table><p>A 24-year-old woman, gravida 2 para 1, comes to the office for follow-up.&nbsp; She has a history of asthma and recently read about new research suggesting that polyunsaturated fatty acid supplementation in pregnancy could reduce the risk of asthma in offspring.</p><p><strong>Item 1 of 2</strong></p><p>According to the overall results shown in the abstract, approximately how many pregnant women would need to be treated with polyunsaturated fatty acid supplementation to prevent a case of asthma among offspring?</p>",
            "questionHeader": "",
            "explanationText": "<p>The <strong>number needed to treat</strong> (NNT) provides an estimate of the effectiveness of a treatment or intervention.&nbsp; NNT can be calculated as the <strong>inverse</strong> of the <strong>absolute risk reduction</strong> (ARR); mathematically, NNT = 1/ARR.</p><p>In this study, 700 pregnant women between 22 and 26 weeks gestation were randomized to either long-chain polyunsaturated fatty acid (LcPUFA) supplementation or placebo.&nbsp; Their children (700 in total, according to the abstract) were followed for 3 years, and the rates of asthma among the children were determined.&nbsp; Based on the overall data from all 700 children, 24.3% of the children of women who had received placebo during pregnancy developed asthma, in contrast to 17.1% of the children of women who had received LcPUFA supplementation during pregnancy.&nbsp; These percentages represent the risk of asthma among offspring in the 2 groups.&nbsp; Therefore:</p><p align=\"center\">ARR = 24.3% &#8722; 17.1% = 7.2%</p><p align=\"center\">NNT = 1/7.2% = 1/0.072 = 13.89 or ~14</p><p>This means that, for every 14 women who receive polyunsaturated fatty acid supplementation during pregnancy, 1 case of asthma among their offspring is prevented.</p><p>The ideal value for NNT is NNT = 1, meaning that for every patient who receives a treatment or intervention, one patient benefits.&nbsp; Some clinicians feel that the NNT is more practical at estimating an intervention&#39;s benefit than the ARR or other measures (eg, relative risk ratio).</p><p><strong>Educational objective:</strong><br>The number needed to treat is the reciprocal of the absolute risk reduction rate from an intervention.&nbsp; This number is used by some clinicians to present probabilities regarding outcomes to patients.</p>",
            "abstractId": 307,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 1652,
            "topic": "Number Needed To Treat",
            "titleId": 1652,
            "title": "Number Needed To Treat",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 11512,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "7",
                    "choiceNumber": 1,
                    "correctTaken": 1051,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "14",
                    "choiceNumber": 2,
                    "correctTaken": 7228,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "30",
                    "choiceNumber": 3,
                    "correctTaken": 1945,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "41",
                    "choiceNumber": 4,
                    "correctTaken": 937,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "50",
                    "choiceNumber": 5,
                    "correctTaken": 519,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "7873954",
                    "mediaDataId": 0,
                    "title": "Number needed to treat",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/7873954",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 158,
            "notes": null,
            "peopleTaken": 11680,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 552,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 11513,
            "questionIndex": 12674,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>The table shows the risk of asthma in the 2 groups with the children stratified according to baseline maternal blood levels of long-chain polyunsaturated fatty acids (LcPUFA).&nbsp; The mothers were divided in tertiles based on LcPUFA levels measured at the initiation of the trial.&nbsp; Based on these data, which of the following conclusions is most accurate?</p>",
            "questionHeader": "",
            "explanationText": "<p>The <strong>children</strong> were stratified based on baseline <strong>maternal</strong> levels of long-chain polyunsaturated fatty acids (LcPUFAs).&nbsp; A statistically significant difference in asthma incidence between the LcPUFA and the placebo groups was found only among the children of women in the lowest third in terms of baseline levels of LcPUFAs (lowest tertile).&nbsp; Among these children, the absolute risk reduction (ARR) in asthma risk between the LcPUFA and the placebo group was 29.8% &#8722; 18.1% = 11.7, with a <em>p</em>-value (<em>p</em> = 0.04) that was statistically significant (&lt;0.05).&nbsp; In contrast, there was no statistically significant difference in asthma risk between the children of women in the middle tertile and those of women in the highest tertile in terms of baseline LcPUFA levels (17.1% versus 17.9% with <em>p</em> = 0.87 in the middle tertile and 19.8% versus 21.4% with <em>p</em> = 0.77 in the highest tertile).</p><p>These results suggest that the protective effects of LcPUFAs noted in the overall study (ARR = 7.2% as calculated in the prior question) come mostly from children of women with low baseline LcPUFAs.&nbsp; Therefore, in the future, it may be beneficial to tailor personalized medicine (ie, precision medicine) approaches to target such women.&nbsp; Such approaches take into account individual factors (eg, genotype, family history) to develop diagnostic and therapeutic interventions.</p><p><strong>(Choice A)</strong>&nbsp; This difference (17.9% &#8722; 17.1% = 0.8%) represents the absolute, not relative, reduction in risk of asthma among children whose mothers were in the middle tertile of LcPUFA levels.&nbsp; The relative risk reduction is given by (17.9% &#8722; 17.1%)/17.9% = 0.8%/17.9% = 0.045 = 4.5%.</p><p><strong>(Choice B)</strong>&nbsp; In the highest tertile (ie, women with high baseline LcPUFA levels), there was no statistically significant difference in risk of asthma between the offspring of women treated with LcPUFA and the offspring of women who had received placebo during their pregnancy, as the <em>p</em>-value is &gt;0.05.</p><p><strong>(Choice C)</strong>&nbsp; Leukotrienes mediate inflammatory manifestations of asthma (eg, bronchoconstriction, mucus secretion) and can be displaced by higher LcPUFA levels.&nbsp; However, the abstract provides no information regarding leukotriene inhibitor use.</p><p><strong>(Choice E)</strong>&nbsp; Overall, there was a statistically significant association between LcPUFA supplementation and risk of asthma among the offspring (<em>p</em> = 0.01).</p><p><strong>Educational objective:</strong><br>Stratification can help clarify the association between 2 variables.</p>",
            "abstractId": 307,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24338,
            "topic": "Interpretation and use of evidence-based data (including individualization, risk-benefit analysis, synthesis of concepts with real data)",
            "titleId": 24338,
            "title": "Interpretation and use of evidence-based data (including individualization, risk-benefit analysis, synthesis of concepts with real data)",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 11512,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Children of women in the middle tertile had a 0.8% relative risk reduction in asthma with LcPUFA supplementation.",
                    "choiceNumber": 1,
                    "correctTaken": 983,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LcPUFA supplementation should be offered to women with high baseline LcPUFA levels to reduce asthma risk among their offspring.",
                    "choiceNumber": 2,
                    "correctTaken": 454,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Leukotriene inhibitor use is likely beneficial in all pregnant women as it will increase LcPUFA levels",
                    "choiceNumber": 3,
                    "correctTaken": 271,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Personalized medicine efforts geared toward women with low baseline LcPUFA levels may be beneficial in decreasing asthma risk among their offspring.",
                    "choiceNumber": 4,
                    "correctTaken": 8765,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The results of the stratified data show that the association between LcPUFA supplementation and offspring asthma is not statistically significant overall.",
                    "choiceNumber": 5,
                    "correctTaken": 1204,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 88,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 11677,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 271,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 20299,
            "questionIndex": 21797,
            "questionText": "<p>A group of university researchers developed a new rapid test for sickle cell disease (SCD) that can provide a result in as little as 1 minute.&nbsp; The technology uses ultrasound to heat a protein sample and then measures how it dissolves over time to identify the protein responsible for SCD.&nbsp; The test is relatively inexpensive and requires only a simple camera (such as one on a smartphone), a power source, and a microscope.&nbsp; A preliminary evaluation of the performance of the test showed that 99% of all individuals with a positive test result had SCD, and that 94% of all individuals with a negative test result did not have SCD.&nbsp; Based on these preliminary data, which of the following is the most accurate interpretation of the results?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32272\"><table class=\"table-default-style table-header-footer-style\" style=\"width:82.36%\"><tbody><tr><td style=\"width:30.36%; border:none;\"></td><td style=\"width:24.2%;\"><p align=\"center\"><strong>Positive condition</strong></p></td><td style=\"width:24.36%;\"><p align=\"center\"><strong>Negative condition</strong></p></td><td style=\"width:24.36%; border:none;\"></td></tr><tr><td style=\"width:30.36%;\"><p align=\"center\"><strong>Positive test result</strong></p></td><td style=\"width:24.2%;\"><p align=\"center\">TP</p></td><td style=\"width:24.36%;\"><p align=\"center\">FP</p></td><td style=\"width:24.36%;\"><p align=\"center\">PPV =<br />TP / (TP + FP)</p></td></tr><tr><td style=\"width:30.36%\"><p align=\"center\"><strong>Negative test result</strong></p></td><td style=\"width:24.2%\"><p align=\"center\">FN</p></td><td style=\"width:24.36%\"><p align=\"center\">TN</p></td><td style=\"width:24.36%\"><p align=\"center\">NPV =<br />TN / (TN + FN)</p></td></tr><tr><td style=\"width:30.36%; border:none;\"></td><td style=\"width:24.2%;\"><p align=\"center\">Sensitivity =</p><p align=\"center\">TP / (TP + FN)</p></td><td style=\"width:24.36%;\"><p align=\"center\">Specificity =</p><p align=\"center\">TN / (TN + FP)</p></td><td style=\"width:24.36%; border:none;\"></td></tr><tr><td colspan=\"4\" style=\"width:100.0%;\"><p><strong>FN</strong> = false negative; <strong>FP</strong> = false positive; <strong>NPV</strong> = negative predictive value; <strong>PPV</strong> = positive predictive value; <strong>TN</strong> = true negative; <strong>TP</strong> = true positive.</p></td></tr></tbody></table></div><p>The percentage of all individuals with a positive test result who have the disease (eg, sickle cell disease [SCD]) is known as the <strong>positive predictive value (PPV)</strong> of a test.&nbsp; It is equal to the number of individuals with disease and who test positive (ie, true positive [TP]) divided by the number of all individuals with a positive test result (ie, TP + false positive [FP]):</p><p style=\"text-align:center;\">PPV = TP / (TP + FP)</p><p>In this case, the new SCD test showed that <strong>99%</strong> of all patients with a <strong>positive test</strong> result <strong>had SCD</strong>; therefore, <strong>PPV = 99%</strong>.</p><p>The percentage of all individuals with a negative test result who do not have the disease is known as the <strong>negative predictive value (NPV)</strong> of a test.&nbsp; It is equal to the number of individuals without disease and who test negative (ie, true negative [TN]) divided by the number of all individuals with a negative test result (ie, TN + false negative [FN]):</p><p style=\"text-align:center;\">NPV = TN / (TN + FN)</p><p>The new SCD test showed that <strong>94%</strong> of all patients with a <strong>negative test</strong> result <strong>did not have SCD</strong>; therefore, <strong>NPV = 94%</strong>.</p><p><strong>(Choices A and D)</strong>&nbsp; Sensitivity describes the proportion of individuals with disease for which the test result is positive.&nbsp; It is calculated as TP / (TP + FN); its complement (1 &#8722; sensitivity) is the false-negative rate.&nbsp; Specificity describes the proportion of individuals without disease for which the test result is negative.&nbsp; It is calculated as TN / (TN + FP); its complement (1 &#8722; specificity) is the false-positive rate.</p><p><strong>(Choice B)</strong>&nbsp; Negative likelihood ratio (LR) describes the probability of a negative test result occurring in an individual with disease compared to an individual without disease; it is calculated as (1 &#8722; sensitivity) / specificity.&nbsp; Positive LR describes the probability of a positive test result occurring in an individual with disease compared to an individual without disease; it is calculated as sensitivity / (1 &#8722; specificity).</p><p><strong>Educational objective:</strong><br>Positive predictive value is the probability that an individual has a disease given a positive test result.&nbsp; Negative predictive value is the probability that an individual does not have a disease given a negative test result.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 10211,
            "topic": "Sensitivity, specificity, NPV, PPV",
            "titleId": 10211,
            "title": "Sensitivity, specificity, NPV, PPV",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The false-negative rate is 94%, and the false-positive rate is 99%",
                    "choiceNumber": 1,
                    "correctTaken": 39,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The negative likelihood ratio is 94%, and the positive likelihood ratio is 99%",
                    "choiceNumber": 2,
                    "correctTaken": 405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The negative predictive value is 94%, and the positive predictive value is 99%",
                    "choiceNumber": 3,
                    "correctTaken": 6676,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The sensitivity is 99%, and the specificity is 94%",
                    "choiceNumber": 4,
                    "correctTaken": 3400,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 114,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 10522,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1163,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 23061,
            "questionIndex": 107183,
            "questionText": "<p>A group of researchers conducted a randomized controlled trial to evaluate the benefit of a nutritional intervention for prevention of gestational diabetes mellitus (GDM) in pregnant women with severe obesity (BMI &gt;40 kg/m&sup2;).&nbsp; A total of 800 women with severe obesity and in their first trimester of pregnancy were randomly assigned to the nutritional intervention (treatment) group or the no nutritional intervention (control) group.&nbsp; In addition, information packages on how to maintain physical activity during pregnancy were given as GDM prophylaxis to some participants in each group.&nbsp; An excerpt of study results is shown below.</p><div id=\"div_T83939\"><table class=\"table-No-Border table-default-style\"><tbody><tr><td><p align=\"center\"><strong>Study group</strong></p></td><td><p align=\"center\"><strong>Nutritional<br>intervention</strong></p></td><td><p align=\"center\"><strong>Physical activity<br>package</strong></p></td><td><p align=\"center\"><strong>Rate of<br>GDM (%)</strong></p></td></tr><tr><td><p>Study (<em>n</em> = 200)</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">8</p></td></tr><tr><td><p>Study (<em>n</em> = 200)</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">5</p></td></tr><tr><td><p>Control (<em>n</em> = 200)</p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">20</p></td></tr><tr><td><p>Control (<em>n</em> = 200)</p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">20</p></td></tr></tbody></table></div><p>Among women with no physical activity prophylaxis, which of the following is closest to the relative risk reduction of GDM provided by the nutritional intervention compared to control?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\" style=\"width:40.0%\"><p align=\"center\"><strong>Common measures of therapeutic efficacy</strong></p></td></tr><tr><td style=\"width:20.0%\"><p align=\"center\"><strong>Term</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Definition</strong></p></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Calculation</strong></p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Absolute risk reduction (ARR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating the actual difference in event rate between control &amp; treatment groups</p></td><td style=\"width:40.0%;\"><p align=\"center\">ARR = control rate &ndash; treatment rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk reduction (RRR)</strong></p></td><td style=\"width:40.0%;\"><p>Percentage indicating relative reduction in the treatment event rate compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RRR = ARR / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Relative risk (RR)</strong></p></td><td style=\"width:40.0%;\"><p>Ratio of the probability of an event occurring in the treatment group compared to the control group</p></td><td style=\"width:40.0%;\"><p align=\"center\">RR = treatment rate / control rate</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Number needed to treat (NNT)</strong></p></td><td style=\"width:40.0%;\"><p>Number of individuals who need to be treated to prevent a negative outcome in 1 patient</p></td><td style=\"width:40.0%;\"><p align=\"center\">NNT = 1 / ARR</p></td></tr></tbody></table></div><p><strong>Relative risk reduction (RRR)</strong> describes the <strong>difference in risk</strong> (or rate) of an unfavorable outcome (eg, gestational diabetes mellitus [GDM]) between a treatment group (eg, nutritional intervention) and a control group (eg, no nutritional intervention) <strong>relative to the control group</strong> (ie, proportion of decreased risk due to treatment compared with the control group).&nbsp; RRR is calculated as follows:</p><p style=\"text-align: center;\"><strong>RRR</strong> = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>) / Risk<font size=\"2\"><sub>control</sub></font></p><p>This study evaluated the benefit of a nutritional intervention in preventing GDM in pregnant women with severe obesity.&nbsp; Participants were randomly assigned to the intervention (treatment) group or the control group.&nbsp; In addition, some participants received information on physical activity as prophylaxis.</p><p>To determine <strong>RRR of GDM</strong> provided by the nutritional intervention compared with control among <strong>women with no</strong> physical activity <strong>prophylaxis</strong>, only the data for women with no physical activity prophylaxis should be considered.&nbsp; Based on the findings presented in the table, Risk<font size=\"2\"><sub>control</sub></font> and Risk<font size=\"2\"><sub>treatment</sub></font> are as follows:</p><ul><li>Rate of GDM in the control group with no physical activity prophylaxis: <strong>Risk<font size=\"2\"><sub>control</sub></font> =</strong> 20% =&nbsp;<strong>0.20</strong></li><li>Rate of GDM in the intervention group with no physical activity prophylaxis: <strong>Risk</strong><font size=\"2\"><sub><strong>treatment</strong></sub></font>&nbsp;<strong>= </strong>8% = <strong>0.08</strong></li></ul><p>Therefore, RRR for GDM in the intervention group is calculated as:</p><p style=\"text-align: center;\"><strong>RRR</strong> = (0.20 &#8722; 0.08) / 0.20 = <strong>0.60 (or 60%)</strong></p><p>This finding indicates that, relative to no intervention, the nutritional intervention reduced the risk of GDM by 60% in this study population.</p><p>RRR also may be calculated using relative risk (RR):</p><p style=\"text-align: center;\">RRR = 1 &#8722; RR</p><p>For this question, RR is the ratio of the risk of GDM in the intervention group to the risk of GDM in the control group:</p><p style=\"text-align: center;\">RR = (Risk<font size=\"2\"><sub>treatment</sub></font> / Risk<font size=\"2\"><sub>control</sub></font>) = (0.08 / 0.20) = 0.40</p><p>Therefore:</p><p style=\"text-align: center;\">RRR = 1 &#8722; 0.40 = 0.60 (or 60%)</p><p><strong>(Choices A and B)</strong>&nbsp; Findings of 12% and 15% represent the absolute risk reduction (ARR) for GDM provided by the nutritional intervention compared with control among women without physical activity prophylaxis (0.20 &#8722; 0.08 = 0.12, or 12%) and with physical activity prophylaxis (0.20 &#8722; 0.05 = 0.15, or 15%).</p><p><strong>(Choice D)</strong>&nbsp; The RRR for GDM provided by the nutritional intervention compared with control among women with physical activity prophylaxis is (0.20 &#8722; 0.05) / 0.20 = 0.75, or 75%.</p><p><strong>Educational objective:</strong><br>Relative risk reduction (RRR) measures how much a treatment reduces the risk (ie, rate) of an unfavorable outcome.&nbsp; RRR may be calculated using absolute risk reduction (ARR) or relative risk (RR).</p><p style=\"text-align: center;\">RRR = ARR / Risk<font size=\"2\"><sub>control</sub></font> = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>) / Risk<font size=\"2\"><sub>control</sub></font></p><p style=\"text-align: center;\">RRR = 1 &#8722; RR = 1 &#8722; (Risk<font size=\"2\"><sub>treatment</sub></font> / Risk<font size=\"2\"><sub>control</sub></font>)</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20684,
            "topic": "Risk",
            "titleId": 20684,
            "title": "Risk",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "12%",
                    "choiceNumber": 1,
                    "correctTaken": 2265,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "15%",
                    "choiceNumber": 2,
                    "correctTaken": 744,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "60%",
                    "choiceNumber": 3,
                    "correctTaken": 7108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "75%",
                    "choiceNumber": 4,
                    "correctTaken": 477,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 205,
            "othersAvgTimeSpent": 111,
            "notes": null,
            "peopleTaken": 10594,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 252,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 3885,
            "questionIndex": 3885,
            "questionText": "A prospective cohort study revealed a strong positive association between smoking and liver cirrhosis (relative risk&nbsp; = 2.8).&nbsp; The researchers then divided the cohort into two groups: alcohol consumers and non-consumers.&nbsp; Subsequent statistical analysis did not reveal any association between smoking and liver cirrhosis with either group.&nbsp; The scenario described above is an example of which of the following?",
            "questionHeader": "",
            "explanationText": "<P>Confounding refers to the bias that results when the exposure-disease relationship is mixed with the effect of extraneous factors (i.e., confounders).&nbsp; Confounders influence both the exposure and outcome.&nbsp; In the given study, crude analysis of the data initially revealed an association between smoking and liver cirrhosis.&nbsp; The most likely potential confounder is concomitant alcohol consumption in people who smoke.&nbsp; It is a well-known fact that alcohol consumption is strongly associated with liver cirrhosis.&nbsp; Furthermore, alcohol consumption can explain at least part of the association observed between smoking and liver cirrhosis.</P><P>Methods to deal with confounding include matching of cases and controls based on the confounding factor, or stratification of the study population based on the confounding factor.&nbsp; In this case, running separate analyses for alcohol consumers and non-consumers (this technique is called stratified analysis) can unmask confounding and disclose the true unconfounded value of the RR.</P><P><STRONG>(Choice A)</STRONG> Selection bias results from the manner in which people are selected for the study, or from the selective losses from follow-up.&nbsp; The scenario does not mention any of these problems.</P><P><STRONG>(Choices B and C)</STRONG> Observer's bias and measurement bias distort the measure of association by misclassifying exposed/unexposed and/or diseased/non-diseased subjects.&nbsp; The scenario does not describe this classification process.</P><P><STRONG>(Choice D)</STRONG> Recall bias results from the inaccurate recall of past exposure by people in the study.&nbsp; It applies mostly to case-control studies, not cohort studies.</P><P><STRONG>Educational Ojective:</STRONG><BR>Know the concept of confounding.&nbsp; Distinguish between crude and adjusted measures of association.&nbsp; Confounding&nbsp; refers to the bias that can result when the exposure-disease relationship is mixed with the effect of extraneous factors (i.e., confounders).</P>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6409,
            "topic": "Confounding, effect modification, bias, errors",
            "titleId": 6409,
            "title": "Confounding, effect modification, bias, errors",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 1,
                    "correctTaken": 28892,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer's bias",
                    "choiceNumber": 2,
                    "correctTaken": 8244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement bias",
                    "choiceNumber": 3,
                    "correctTaken": 14390,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recall bias",
                    "choiceNumber": 4,
                    "correctTaken": 5148,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Confounding",
                    "choiceNumber": 5,
                    "correctTaken": 238560,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "848,1050,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 41,
            "othersAvgTimeSpent": 32,
            "notes": null,
            "peopleTaken": 295234,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 276,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 20859,
            "questionIndex": 22361,
            "questionText": "<p>The administration of a university hospital conducted a cross-sectional study of errors in the medication use process (MUP) across all hospital departments.&nbsp; The MUP incorporates a wide variety of scenarios, including timing errors, dosing errors, and adverse events.&nbsp; The results of the study showed that in a random sample of 360 patients receiving treatment in the emergency department, the prevalence of MUP errors is 32.7% (95% confidence interval: 24.3-41.4).&nbsp; The director of the emergency department had previously reported that the prevalence of medication errors was approximately 25%.&nbsp; Based on these data, which of the following conclusions is most appropriate?</p>",
            "questionHeader": "",
            "explanationText": "<p>A <em><strong>C</strong></em><strong>% confidence interval (CI)</strong> is a range of plausible values calculated from sample data that captures the true population value with a <em>C</em>% confidence level.&nbsp; This means that the <strong>true population value</strong> could be <strong>any value in the CI</strong> (at that confidence level).&nbsp; Therefore, a CI offers the necessary information to evaluate whether there is statistical <strong>evidence in favor of or against a claim</strong> about the true population value.</p><p>In this case, the prevalence of errors in the medication use process is estimated at 32.7%, but it could be <strong>any value between 24.3% and 41.4%</strong> (at a 95% confidence level) due to sampling variation <strong>(Choice A)</strong>.&nbsp; Because the CI (24.3-41.4) includes 25% (ie, the director&#39;s reported prevalence), it is possible that the real prevalence of medication errors is 25%.&nbsp; Therefore, <strong>results do not contradict the director</strong>.</p><p><strong>(Choice B)</strong>&nbsp; An ecological fallacy occurs when conclusions are made about individuals based on studies in which the unit of analysis is a group (eg, country-level data); the conclusions of a study assessing population groups do not necessarily apply to individuals.&nbsp; Although the setting in this study is institutional (ie, every department in the hospital), the unit of analysis is the individual (ie, 360 patients receiving treatment in the emergency department).</p><p><strong>(Choice D)</strong>&nbsp; A cross-sectional study may be descriptive or analytical.&nbsp; It typically takes a snapshot of a population and measures frequency (eg, prevalence) of disease (ie, descriptive design).&nbsp; However, this design may also measure frequency of risk factors and disease to conduct hypothesis testing about associations (ie, analytical design).</p><p><strong>Educational objective:</strong><br>A <em>C</em>% confidence interval (CI) is a range of plausible values calculated from sample data that captures the true population value with a <em>C</em>% confidence level.&nbsp; The CI may be used to evaluate claims about population values.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 8373,
            "topic": "P-value and confidence interval",
            "titleId": 8373,
            "title": "P-value and confidence interval",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The director is incorrect because the estimated prevalence is 32.7%",
                    "choiceNumber": 1,
                    "correctTaken": 314,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The results are affected by ecological fallacy because they involve all hospital departments",
                    "choiceNumber": 2,
                    "correctTaken": 1351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The results do not contradict the director because the confidence interval includes 25%",
                    "choiceNumber": 3,
                    "correctTaken": 7615,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The study cannot evaluate statistical hypotheses because it is a cross-sectional study",
                    "choiceNumber": 4,
                    "correctTaken": 1306,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1340,1672,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 10586,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 471,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 3922,
            "questionIndex": 3922,
            "questionText": "<p>A group of investigators is studying the relationship between a particular 5-lipoxygenase genotype and atherosclerosis.&nbsp; A random sample of patients from a local university hospital is invited to participate in the study.&nbsp; Blood samples for leukocyte genotyping are obtained, and ultrasonography to assess carotid intima-media thickness (CIMT), a marker of atherosclerosis, is performed.&nbsp; Results show that the particular 5-lipoxygenase genotype is associated with abnormally increased CIMT, a predisposition to atherosclerosis.&nbsp; Which of the following best describes this study design?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p>A <strong>cross-sectional</strong> study is an <strong>observational</strong> study design that may be employed to estimate the <strong>prevalence</strong> of disease, or to examine <strong>associations</strong> between risk factors and disease as they exist in a well-defined population at <strong>one particular time</strong>.&nbsp; This type of design typically takes a <strong>snapshot</strong> and measures prevalence of risk factor and outcome simultaneously.</p><p>In this case, subjects are classified according to their risk factor (ie, presence or absence of the particular 5-lipoxygenase genotype) and disease status (ie, presence or absence of abnormally increased carotid intima-media thickness [CIMT]) <strong>at the same time</strong> (ie, snapshot).&nbsp; Then, the association between the presence of the risk factor and the disease is estimated.&nbsp; A major <strong>limitation</strong> of cross-sectional studies is that the temporal relationship between risk factor and disease is not always clear.&nbsp; In this example, however, demonstrating a temporal relationship is possible due to the nature of the risk factor (acquiring a particular genotype precedes atherosclerosis).</p><p><strong>(Choice A)</strong>&nbsp; A case-control study is designed by selecting both patients with a particular disease (cases) and patients without that disease (controls), and then determining their previous exposure status.&nbsp; In this case, the researchers selected a single sample from the target population and categorized subjects according to their presence or absence of the risk factor (ie, a particular 5-lipoxygenase genotype) and disease (ie, CIMT status) at a single point in time.</p><p><strong>(Choices C and E)</strong>&nbsp; In cohort studies, a group of exposed and unexposed subjects is followed over time for development of the outcome of interest.&nbsp; Contrary to the prospective cohort study, in the retrospective case, exposure and outcome have already occurred at the beginning of the study; therefore, exposure and outcome status are ascertained retrospectively.&nbsp; In both prospective and retrospective cohort studies, however, there is a follow-up of exposed and unexposed individuals across time.&nbsp; By contrast, in this example, a snapshot of the subjects was obtained at one particular time.</p><p><strong>(Choice D)</strong>&nbsp; A randomized clinical trial is an experimental study that directly compares &#8805;2 treatments or interventions.&nbsp; Typically, the subjects are randomly assigned to an intervention (eg, a medication) or placebo, and then followed for the development of the outcome of interest (eg, disease).</p><p><strong>Educational objective:</strong><br>In a cross-sectional study, risk factor and outcome are measured simultaneously at a particular point in time (snapshot study).&nbsp; In other study designs, a certain period separates the exposure from the outcome.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Case-control study",
                    "choiceNumber": 1,
                    "correctTaken": 981,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cross-sectional study",
                    "choiceNumber": 2,
                    "correctTaken": 8195,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prospective cohort study",
                    "choiceNumber": 3,
                    "correctTaken": 1569,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Randomized clinical trial",
                    "choiceNumber": 4,
                    "correctTaken": 645,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retrospective cohort study",
                    "choiceNumber": 5,
                    "correctTaken": 834,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 70,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 12224,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 394,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 20685,
            "questionIndex": 22187,
            "questionText": "<p>A case-control study evaluated whether the length of the anogenital distance (AGD)&mdash;a biomarker of in-utero prenatal androgen exposure&mdash;is associated with the presence of endometriosis.&nbsp; Cases (<em>n</em> = 114) were women diagnosed with endometriosis attending the endometriosis unit at a local hospital.&nbsp; Controls (<em>n</em> = 105) were women without endometriosis attending the gynecological outpatient clinic for routine gynecological examinations at the same hospital.&nbsp; Participants completed health questionnaires and underwent physical and gynecological examinations, including transvaginal ultrasound.&nbsp; Measurements from the upper verge of the anus to the posterior fourchette (AGD<font size=\"2\"><sub>AF</sub></font>) were obtained in all subjects.&nbsp; Logistic regression was used to estimate the unadjusted and adjusted association between tertiles of AGD<font size=\"2\"><sub>AF</sub></font> measurements and presence of endometriosis, with tertile 3 used as a baseline.&nbsp; Results for AGD<font size=\"2\"><sub>AF</sub></font> are shown in the diagram below.</p><p><img  draggable=\"false\" id=\"49064\" src=\"https://www.uworld.com/media/highresdefault/L76831.png\"  ></p><p>Based on these results, which of the following is the most appropriate conclusion?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Odds ratio</strong> (OR) is the odds of an exposure (eg, anogenital distance from the posterior fourchette to the upper verge of the anus [AGD<font size=\"2\"><sub>AF</sub></font>]) in cases (eg, women with endometriosis) divided by the odds of that exposure in controls (eg, women without endometriosis).&nbsp; The <strong>confidence interval</strong> (CI) of a given OR indicates, with a certain confidence level (eg, 95%), whether the OR is statistically different from the <strong>null value</strong> (ie, <strong>OR = 1.0</strong>).&nbsp; Any CI that excludes the null value is statistically significant.</p><p>ORs may be adjusted or unadjusted.&nbsp; An <strong>unadjusted OR</strong> estimates the association between an exposure and an outcome but <strong>does not account</strong> (ie, control) for the effect of other variables, known as <strong>confounders</strong> (eg, demographics), on the outcome.&nbsp; An <strong>adjusted OR</strong> accounts (ie, controls) for the effect of confounders.&nbsp; Therefore, adjusting minimizes confounding and provides better estimates of associations.</p><p>This study provides ORs for several levels of exposure (ie, tertiles of AGD<font size=\"2\"><sub>AF</sub></font> measurements) among women with (ie, cases) and without (ie, controls) endometriosis.&nbsp; AGD<font size=\"2\"><sub>AF</sub></font> measurements in the 3rd tertile (ie, longer AGD<font size=\"2\"><sub>AF</sub></font>) are considered baseline (OR = 1).&nbsp; The symbols (eg, circle, triangle) correspond to the point estimates of the ORs, and the lines correspond to the 95% CIs.</p><ul><li><p>Compared with those in the 3rd tertile, women with AGD<font size=\"2\"><sub>AF</sub></font> in the 2nd tertile were not more likely to have endometriosis because all the 95% CIs cross the horizontal line corresponding to OR = 1 (ie, include the null value) <strong>(Choice B)</strong>.</p></li><li><p>In contrast, compared with those in the 3rd tertile, women with AGD<font size=\"2\"><sub>AF</sub></font> in the <strong>1st tertile</strong> were <strong>significantly</strong> more likely to have endometriosis because the ORs were &gt;1 and none of the <strong>95% CIs</strong> crossed the horizontal line corresponding to OR = 1 (ie, <strong>exclude</strong> the null value).</p></li></ul><p>This means that compared to the 3rd tertile, only AGD<font size=\"2\"><sub>AF</sub></font> measurements in the 1st tertile (ie, shorter AGD<font size=\"2\"><sub>AF</sub></font> measurements) were significantly associated with the presence of endometriosis <strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Within each tertile, the adjusted and unadjusted ORs are close in value, and their corresponding CIs overlap.&nbsp; This means that the variables controlled for during the analysis (ie, in the adjusted ORs) did not distort the true association between AGD<font size=\"2\"><sub>AF</sub></font> and endometriosis; if they had distorted the true association, there would have been a considerable difference between the adjusted and unadjusted ORs.</p><p><strong>Educational objective:</strong><br>Odds ratio (OR) is a measure of association between an exposure and an outcome.&nbsp; Confidence intervals that contain the null value are not statistically significant.&nbsp; Adjusted ORs minimize confounding and provide better estimates of associations.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 29979,
            "topic": "Measures of association",
            "titleId": 29979,
            "title": "Measures of association",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age, BMI, vaginal delivery, and episiotomy distorted the true association between AGD<font size=\"2\"><sub>AF</sub></font> and endometriosis.",
                    "choiceNumber": 1,
                    "correctTaken": 525,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Compared to AGD<font size=\"2\"><sub>AF</sub></font> measurements in the 3rd tertile, AGD<font size=\"2\"><sub>AF</sub></font> measurements in the 1st and 2nd tertiles are significantly associated with endometriosis.",
                    "choiceNumber": 2,
                    "correctTaken": 1144,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Only AGD<font size=\"2\"><sub>AF</sub></font> measurements in the 1st tertile are significantly associated with the presence of endometriosis.",
                    "choiceNumber": 3,
                    "correctTaken": 3266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is a statistically significant increase in the odds of endometriosis as AGD<font size=\"2\"><sub>AF</sub></font> distance increases.",
                    "choiceNumber": 4,
                    "correctTaken": 730,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 236,
            "othersAvgTimeSpent": 112,
            "notes": null,
            "peopleTaken": 5665,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1541,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 23519,
            "questionIndex": 107754,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>An obstetrics and gynecology resident wants to conduct a study to evaluate whether a higher serum triglyceride (TG) level early in the first trimester is associated with gestational diabetes mellitus (GDM).&nbsp; The resident intends to enroll pregnant patients who receive regular antenatal care at Hospital X in the study.&nbsp; Serum TG levels will be measured during gestational weeks 6-8 (TG0); participants will then be categorized by result: low TG0: &lt;25th percentile; intermediate TG0: 25th-75th percentile; high TG0: &gt;75th percentile.&nbsp; At 24-28 weeks gestation, the 1&#8208;step oral glucose tolerance test (75 g, 2 hr) will be performed to diagnose GDM.</p><p><strong>Item 1 of 2</strong></p><p>Based on this information, which of the following study designs will the resident use?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/highresdefault/L13767.jpg\"  ></p><p>In this study, participants will be <strong>initially identified</strong> based on their <strong>exposure status</strong>, which will be represented by 1 of 3 different serum triglyceride (TG) levels measured during gestational weeks 6-8 (TG0): low TG0: &lt;25th percentile; intermediate TG0: 25th-75th percentile; high TG0: &gt;75th percentile).&nbsp; The <strong>frequency of the outcome</strong> (ie, gestational diabetes mellitus [GDM]) will be <strong>subsequently compared</strong> among different levels of exposure; therefore, this investigation will be designed as a <strong>cohort study</strong> with 3 levels of exposure <strong>(Choices A, B, and C)</strong>.</p><p>A cohort study may be retrospective or prospective.&nbsp; In a prospective cohort design, the study begins before the outcome has occurred, whereas in a retrospective cohort design, the study begins after the outcome has occurred.&nbsp; In this study, the resident plans to measure serum TG levels during gestational weeks 6-8 and then diagnose GDM at 24-28 weeks gestation.&nbsp; This plan indicates that the resident will <strong>actively follow participants</strong> over time (ie, pregnancy), so the <strong>outcome will not have occurred</strong> at the beginning of the study <strong>(Choice E)</strong>.&nbsp; Therefore, the resident plans to conduct a <strong>prospective cohort study</strong>.</p><p><strong>Educational objective:</strong><br>In a cohort study, participants are initially identified based on their exposure status and then followed over time to assess development of the outcome.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 23519,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Case series",
                    "choiceNumber": 1,
                    "correctTaken": 478,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Case-control",
                    "choiceNumber": 2,
                    "correctTaken": 343,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cross-sectional",
                    "choiceNumber": 3,
                    "correctTaken": 664,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prospective cohort",
                    "choiceNumber": 4,
                    "correctTaken": 10366,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retrospective cohort",
                    "choiceNumber": 5,
                    "correctTaken": 76,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 51,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 11927,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 87,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 197,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 23520,
            "questionIndex": 107755,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>The resident&#39;s attending physician states that conducting the study as designed is not feasible and recommends conducting a retrospective study using data from medical charts.&nbsp; The attending physician suggests inquiring about institutional review board (IRB) and informed consent requirements for studies using data from medical charts.&nbsp; Which of the following will the study proposed by the attending physician require?</p>",
            "questionHeader": "",
            "explanationText": "<p>An <strong>institutional review board (IRB)</strong> is a committee with the authority to review, approve, disapprove, or require modifications in research activities involving human participants.&nbsp; The primary objective of any IRB is to protect the rights and welfare of human subjects involved in research; IRB review ensures that research with human subjects is conducted in accordance with all federal, institutional, and ethical guidelines.&nbsp; All research projects involving human participants must be submitted to an IRB for review and approval before study initiation <strong>(Choices A&nbsp;and D)</strong>.</p><p><strong>Informed consent</strong> is a key component of research ethics.&nbsp; The process involves:</p><ul><li>disclosing to potential research participants information needed to make an informed decision.</li><li>facilitating the understanding of what has been disclosed.</li><li>promoting the voluntary nature of the decision about whether to participate in the research.</li></ul><p>The ethical principle behind informed consent is protection of participant autonomy.&nbsp; In certain types of research, federal regulations allow an <strong>IRB to waive</strong> the <strong>informed consent</strong> requirement because the research will involve <strong>no more than minimal risk</strong> to participants.&nbsp; Waivers of informed consent are primarily requested for research involving <strong>secondary analysis</strong> of <strong>existing data</strong>.</p><p>In this case, the study will be retrospective, and secondary data (ie, medical charts) will be collected.&nbsp; This plan indicates that the IRB will not require the investigators to obtain informed consent because the study will not involve interaction with participants and will consist of no more than minimal risk to them <strong>(Choice B)</strong>.&nbsp; Therefore, the study proposed by the attending physician will require <strong>IRB approval but not informed consent</strong>.</p><p><strong>Educational objective:</strong><br>All research projects involving human participants must be submitted to an institutional review board for review and approval before study initiation.&nbsp; Research studies that use only secondary data (eg, medical charts) and that involve no more than minimal risk to participants do not require informed consent.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6706,
            "topic": "Research ethics",
            "titleId": 6706,
            "title": "Research ethics",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 23519,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Informed consent but not IRB approval",
                    "choiceNumber": 1,
                    "correctTaken": 644,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "IRB approval and informed consent",
                    "choiceNumber": 2,
                    "correctTaken": 3605,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "IRB approval but not informed consent",
                    "choiceNumber": 3,
                    "correctTaken": 7099,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neither IRB approval nor informed consent",
                    "choiceNumber": 4,
                    "correctTaken": 583,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": "1199,1311,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 31,
            "othersAvgTimeSpent": 37,
            "notes": null,
            "peopleTaken": 11931,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1332,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 18977,
            "questionIndex": 20458,
            "questionText": "<p>A randomized, controlled 6-month intervention study is conducted using individuals with mild cognitive impairment (MCI) or dementia.&nbsp; The objective is to determine if the multicomponent therapy MAKS (a German acronym for motor, activities of daily living, cognitive, social) in day care leads to significantly better progression of activities of daily living and cognitive abilities compared to standard treatment.&nbsp; A total of 362 persons with MCI or dementia took part in the trial, 208 of whom were randomized to the MAKS group and 154 to the control group.&nbsp; At the end of the 6-month intervention phase, the sample consisted of 271 individuals, excluding 55 dropouts in the MAKS group and 36 in the control group.&nbsp; The reasons for dropping out included death, transfer to a different nursing home, termination of day care, and treatment not implemented as indicated.&nbsp; The data analysis is conducted to follow a per-protocol approach.&nbsp; Which of the following describes how the data pertaining to dropouts should be treated to conduct such an analysis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"42545\" src=\"https://www.uworld.com/media/L68081.png\" ></p><p><strong>Per-protocol (PP) analysis</strong> compares treatment groups in a randomized trial by including in the analysis only those participants who <strong>strictly adhered</strong> (eg, nondropouts) and <strong>completed the protocol</strong>.</p><p>Dropouts may bias estimates of treatment effect.&nbsp; For example, in a placebo-controlled randomized trial of a new drug (ie, treatment vs control group), adverse effects may cause a greater proportion of sicker patients to drop out from the treatment group than from the control group.&nbsp; At the trial&#39;s conclusion, the treatment group may end up with a smaller proportion of more severely ill patients than the control group (eg, selection bias).&nbsp; This result could distort the estimation of the effect of a treatment (eg, confounding bias).</p><p>By <strong>excluding dropouts</strong>, PP analysis provides an estimate of the <strong>true effect</strong> of an intervention <strong>assuming a perfect scenario</strong> in which all participants were retained and completed treatments as planned.&nbsp; However, this <strong>overestimates</strong> the effect of the intervention in a realistic (ie, <strong>practical</strong>) <strong>clinical setting</strong>, which almost inevitably includes dropouts.&nbsp; In accordance with PP analysis, all 91 dropouts should be excluded from analysis <strong>(Choices A, B, and E)</strong>.</p><p>In contrast, an analysis that includes all participants as initially allocated after randomization regardless of what happens during the study period (ie, keeping all 91 dropouts in their respective groups for analysis) follows an <strong>intention-to-treat (ITT) principle</strong><strong> (Choice D)</strong>.&nbsp; ITT analysis could lead to a more <strong>conservative</strong> estimate of the effect of the intervention; however, because it closely mirrors the expected number of dropouts in a real-life situation, ITT analysis reflects the <strong>expected effect</strong> of the intervention in a realistic (ie, practical) clinical setting.</p><p><strong>Educational objective:</strong><br>Per-protocol analysis includes only those participants who strictly adhered (ie, nondropouts) to the study protocol.&nbsp; This approach tends to provide an estimate of the true effect of an intervention for a perfect scenario, but it overestimates the effect of the intervention in a practical clinical setting.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15219,
            "topic": "Randomized control trials",
            "titleId": 15219,
            "title": "Randomized control trials",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Exclude the 36 dropouts in the control group from analysis",
                    "choiceNumber": 1,
                    "correctTaken": 45,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exclude the 55 dropouts in the MAKS group from analysis",
                    "choiceNumber": 2,
                    "correctTaken": 137,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exclude the 91 dropouts from analysis",
                    "choiceNumber": 3,
                    "correctTaken": 4983,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Keep all 91 dropouts in their respective groups for analysis",
                    "choiceNumber": 4,
                    "correctTaken": 4580,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform separate analyses for dropouts and nondropouts",
                    "choiceNumber": 5,
                    "correctTaken": 808,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 101,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 10554,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 228,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 20861,
            "questionIndex": 22363,
            "questionText": "<p>A randomized placebo-controlled trial is conducted to compare the effectiveness of a new drug versus placebo for the treatment of hallucinations and delusions associated with Parkinson disease (PD).&nbsp; A total of 60 patients diagnosed with severe PD psychosis are randomly assigned to receive either the new drug (<em>n</em> = 30) or placebo (<em>n</em> = 30).&nbsp; The primary outcome is change in PD-Adapted Scale for Assessment of Positive Symptoms (SAPS-PD).&nbsp; A group of independent and blinded raters administered the SAPS-PD to measure the frequency and severity of hallucinations and delusions of all participants at baseline and week 6.&nbsp; The results of the study showed that the new drug is significantly more effective in reducing the frequency and severity of hallucinations and delusions (<em>p</em> &lt; 0.01).&nbsp; Compared to an unblinded trial, which of the following is the effect of including a group of independent, blinded raters in this trial?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35807\"><table class=\"table-default-style\"><tbody><tr><td style=\"width:20.0%;\"></td><td style=\"width:40.0%;\"><p align=\"center\"><strong>Internal validity</strong></p></td><td style=\"width:40.0%;\"><p align=\"center\"><strong>External validity</strong></p></td></tr><tr><td rowspan=\"3\" style=\"width:20.0%\"><p align=\"center\"><strong>Characteristics</strong></p></td><td style=\"width:40.0%\"><p>Describes causality (ie, if change in independent variable causes change in dependent variable)</p></td><td style=\"width:40.0%\"><p>Describes generalizability (ie, if observed relationship applies to situations or people outside study)</p></td></tr><tr><td style=\"width:40.0%\"><p>&uarr; As study becomes more tightly controlled</p></td><td style=\"width:40.0%\"><p>&darr; As study becomes more tightly controlled</p></td></tr><tr><td style=\"width:40.0%\"><p>&darr; As study becomes more like the real world</p></td><td style=\"width:40.0%\"><p>&uarr; As study becomes more like the real world</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Threats to validity</strong></p></td><td style=\"width:40.0%;\"><p>Bias due to:</p><ul><li>Confounding</li><li>History</li><li>Maturation</li><li>Measurement</li><li>Regression toward the mean</li><li>Repeated testing</li><li>Selection</li></ul></td><td style=\"width:40.0%;\"><p>Bias due to:</p><ul><li>Artificial research environment</li><li>Measurement effects</li><li>Nonrepresentative sample</li></ul></td></tr></tbody></table></div><p><strong>Internal validity</strong> refers to the ability of a study design to provide <strong>evidence of a causal relationship</strong> between a treatment (eg, new drug) and an outcome (eg, hallucinations).&nbsp; The internal validity of a study is threatened when factors other than the treatment can potentially explain the relationship found in a study.&nbsp; One such factor is measurement bias&mdash;the misclassification of exposure and/or outcome (eg, labeling diseased as nondiseased and vice versa) in a study.&nbsp; <strong>Blinding</strong> those who collect or measure data in a study <strong>reduces</strong> the likelihood of <strong>measurement bias</strong> that arises from being aware of treatment assignments and, consequently, increases the internal validity of the study.</p><p>In this trial, participants diagnosed with severe Parkinson disease (PD) psychosis are randomly assigned to receive either the new drug or placebo.&nbsp; The study employed a group of <strong>independent and blinded raters</strong> to administer the PD-Adapted Scale for Assessment of Positive Symptoms and measure the frequency and severity of symptoms for all participants.&nbsp; Blinding those who collect and measure data to the treatment each participant is receiving reduces measurement bias, which ultimately <strong>increases the internal validity</strong> of the study.</p><p><strong>(Choice A)</strong>&nbsp; An unequal loss of participants from study groups in follow-up (eg, cohort, experimental) studies is known as attrition bias.&nbsp; This study provides no information to evaluate attrition.</p><p><strong>(Choice B)</strong>&nbsp; Nonresponse bias may occur when a proportion of study participants become nonrespondents.&nbsp; Nonresponse typically affects studies that use questionnaires or surveys to collect data from participants.&nbsp; This study provides no information to evaluate nonresponse bias.</p><p><strong>(Choice C)</strong>&nbsp; Failure to show a statistically significant association between a treatment and an outcome is often due to insufficient power (eg, due to a small sample size) to detect an association.&nbsp; This study showed a significant difference between groups (<em>p</em> &lt; 0.01), so the study had sufficient power to provide evidence of a causal relationship.</p><p><strong>(Choice D)</strong>&nbsp; Because the study enrolled only patients with severe PD-related psychosis, its results only generalize to this specific population of patients.&nbsp; This choice of study population reduces the study&#39;s external validity (the applicability of study results beyond the specific population studied).</p><p><strong>Educational objective:</strong><br>Internal validity refers to the ability of a research design to provide evidence of a causal relationship between a treatment and an outcome.&nbsp; Blinding increases the internal validity of a study.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20447,
            "topic": "Validity And Reliability",
            "titleId": 20447,
            "title": "Validity And Reliability",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreases loss to follow-up",
                    "choiceNumber": 1,
                    "correctTaken": 50,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreases nonresponse bias",
                    "choiceNumber": 2,
                    "correctTaken": 424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreases statistical power",
                    "choiceNumber": 3,
                    "correctTaken": 117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increases external validity",
                    "choiceNumber": 4,
                    "correctTaken": 2391,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increases internal validity",
                    "choiceNumber": 5,
                    "correctTaken": 7545,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2735,3026,true,-1,1*490,585,true,-1,1*600,676,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 10527,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2650,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": [
        {
            "id": 2,
            "title": "",
            "header": null,
            "text": "<p><b>Risk of Hyperkalemia in Non-diabetic Patients with Chronic Kidney Disease Receiving Antihypertensive Therapy</b></p>\n<p><b>Objective:</b></p>\n<p>Explore the incidence and factors associated with hyperkalemia in patients with chronic kidney disease (CKD) treated with antihypertensive drugs</p>\n<p><b>Methods:</b></p>\n<p><i>Design:</i> Randomized clinical trial</p>\n<p><i>Blinding:</i> Double-blinded</p>\n<p><i>Follow-up:</i> 3 to 6.4 years</p>\n<p><i>Setting:</i> Multicenter (21 medical centers)</p>\n<p><i>Patients:</i> African American patients, aged 18 to 70 years, with hypertensive CKD as defined by a diastolic blood pressure (BP) higher than 95 mm Hg and a glomerular filtration rate (GFR) between 20 and 65 mL/min/1.73 m<sup><font size=\"2\">2</font></sup>.&nbsp; Specific exclusion criteria included diabetes mellitus; urinary protein to urinary creatinine ratio (UP/Cr) higher than 2.5; accelerated or malignant hypertension; secondary hypertension; serious systemic disease; congestive heart failure; and initial potassium level higher than 5.5 mEq/L.</p>\n<p><i>Intervention:</i> Patients were randomized to initial treatment with either a beta-blocker (metoprolol), an ACE inhibitor (ramipril), or a calcium channel blocker (amlodipine) and to 1 of 2 mean arterial BP goals (102-107 mmHg or &lt;92 mmHg).</p>\n<p><i>Outcome measures:</i> hyperkalemic event (potassium level higher than 5.5 mEq/L).</p>\n<p><b>Results:</b></p>\n<p>A total of 1094 non-diabetic patients were randomized. A total of 6497 potassium measurements were obtained, and 80 hyperkalemic events in 51 subjects were identified.</p>\n<p><img id=\"8731\"  alt=\"\" src=\"https://www.uworld.com/media/L29128.jpg\" draggable=\"false\" ></p>\n<p><img id=\"8732\"  alt=\"\" src=\"https://www.uworld.com/media/L29129.jpg\" draggable=\"false\" ></p>\n<p><b>Conclusion:</b></p>\n<p>In non-diabetic patients with hypertensive CKD treated with ACEIs, the risk of hyperkalemia is small.</p>\n<p><i>Funding Source:</i> The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant; additional financial support from the Office of Research in Minority Health and drug donations from Pfizer Inc, AstraZeneca Pharmaceuticals, and King Pharmaceuticals.</p>\n<p><i>Structured abstract is based on:</i> Arch Intern Med. 2009;169(17):1587-94</p>\n",
            "difficultyLevelId": 0,
            "poolTypeId": 1,
            "categoryTypeId": 0,
            "abstractAdoptedFrom": "",
            "source": null,
            "sourceLink": null,
            "vocabularyList": null,
            "qbankId": 2,
            "footnotesList": null,
            "abstractCitation": null,
            "passagePreviewList": null,
            "annotations": null
        },
        {
            "id": 307,
            "title": "Polyunsaturated fatty acid supplementation in pregnancy and risk of asthma in offspring",
            "header": null,
            "text": "<p><strong>Hypothesis:</strong>&nbsp; Providing long-chain polyunsaturated fatty acid supplementation to pregnant women decreases the risk of asthma in their children.</p><p><strong>Methods:</strong></p><div style=\"margin-left:3em !important\"><p><em>Design:</em>&nbsp; Randomized, double-blind, placebo-controlled trial</p><p><em>Setting:</em>&nbsp; Pregnant women at a single center in Europe</p><p><em>Patients:</em>&nbsp; 700 pregnant women between 22 and 26 weeks gestation</p><p><em>Exposure variable:&nbsp;</em>&nbsp;Long-chain polyunsaturated fatty acids supplementation during pregnancy</p><p><em>Outcome measure:</em>&nbsp; Diagnosis of asthma in offspring of patients</p><p><em>Follow-up:&nbsp;</em>&nbsp;Double-blind follow-up period of 3 years with 700 children</p><p><em>Data analysis:</em>&nbsp; Hazard ratio of asthma in children using Kaplan-Meier curves and Cox proportional hazards regression models</p></div><p><strong>Results:</strong></p><div class=\"equation-scroll\"><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\"><tbody align=\"center\"><tr><td colspan=\"2\"></td><td><p style=\"text-align: center;\">Children with<br />diagnosis of<br />asthma<br />(# with asthma/total)</p></td><td><p style=\"text-align: center;\">LcPUFA<br />(<em>N</em> = 350)</p></td><td><p style=\"text-align: center;\">Placebo<br />(<em>N</em> = 350)</p></td><td style=\"text-align: center;\">Hazard<br />ratio</td><td style=\"text-align: center;\">95%<br />confidence<br />interval</td><td style=\"text-align: center;\"><em>p</em>-value</td></tr><tr><td colspan=\"2\" style=\"text-align: left;\">All children</td><td style=\"text-align: center;\">145/700</td><td style=\"text-align: center;\">17.1%</td><td style=\"text-align: center;\">24.3%</td><td style=\"text-align: center;\">0.71</td><td style=\"text-align: center;\">0.53-0.95</td><td style=\"text-align: center;\">0.01</td></tr><tr><td rowspan=\"3\" style=\"text-align: left;\">Children<br />stratified based<br />on baseline<br />maternal levels<br />of LcPUFA</td><td>Lowest<br />tertile</td><td style=\"text-align: center;\">56/233</td><td style=\"text-align: center;\">18.1%</td><td style=\"text-align: center;\">29.8%</td><td style=\"text-align: center;\">0.61</td><td style=\"text-align: center;\">0.38-0.97</td><td style=\"text-align: center;\">0.04</td></tr><tr><td>Middle<br />tertile</td><td style=\"text-align: center;\">41/234</td><td style=\"text-align: center;\">17.1%</td><td style=\"text-align: center;\">17.9%</td><td style=\"text-align: center;\">0.96</td><td style=\"text-align: center;\">0.55-1.66</td><td style=\"text-align: center;\">0.87</td></tr><tr><td>Highest<br />tertile</td><td style=\"text-align: center;\">48/233</td><td style=\"text-align: center;\">19.8%</td><td style=\"text-align: center;\">21.4%</td><td style=\"text-align: center;\">0.93</td><td><p style=\"text-align: center;\">0.56-1.54</p></td><td><p style=\"text-align: center;\">0.77</p></td></tr><tr><td align=\"left\" colspan=\"8\">&nbsp;LcPUFA = long-chain polyunsaturated fatty acids.</td></tr></tbody></table></div>",
            "difficultyLevelId": 0,
            "poolTypeId": 1,
            "categoryTypeId": 0,
            "abstractAdoptedFrom": "",
            "source": null,
            "sourceLink": null,
            "vocabularyList": null,
            "qbankId": 2,
            "footnotesList": null,
            "abstractCitation": null,
            "passagePreviewList": null,
            "annotations": null
        }
    ],
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}